Pulmocide
London
About Pulmocide
Pulmocide Ltd, a company focused on the discovery and development of a new generation of inhaled medicines for the treatment of serious viral and fungal infections of the respiratory tract.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $205.5M
- Funding stage: Late Stage Venture
- Last round: Series C (Dec 2022)
- Website: pulmocide.com
- Phone: +44 207 594 1210
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/pulmocide-35022 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.